Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson, Scott M. Grundy, John J.P. Kastelein, Michel Komajda, José López‐Sendón, Lori Mosca, Jean‐Claude Tardif, David D. Waters, Charles L. Shear, James H. Revkin, Kevin A. Buhr, Marian R. Fisher, Alan R. Tall, Bryan Brewer

New England Journal of Medicine, 2007

The Heart Research Institute, St Bartholomew's Hospital, Karolinska University Hospital, The University of Texas Southwestern Medical Center, University of Amsterdam, Academic Medical Center, Sorbonne Université, Hospital Universitario La Paz, Columbia University, Montreal Heart Institute, San Francisco General Hospital, Pfizer (United States), University of Wisconsin–Madison, Columbia University Irving Medical Center, MedStar Health

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

3120

Citations

View on Google Scholar

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Abstract

Journal Details

Join JournalsHub

Welcome Back